Bibliographic Details
| Title: |
Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial |
| Authors: |
David Cibula, Pawel Knapp, Bohuslav Melichar, Jiřina Bartůňková, Radek Špíšek, Lukas Rob, Jitka Fucikova, Peter Mallmann, Lubos Minar, Marek Pluta, Jaroslav Klát, Jirí Špacek, Pavel Bartos, Josef Chovanec, Petr Valha, Zdenek Novotny, Dariusz Kieszko, Tereza Hrnciarova, Roman Pawel Korolkiewicz, Marek Hraska |
| Source: |
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022) |
| Publisher Information: |
BMJ Publishing Group, 2022. |
| Publication Year: |
2022 |
| Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Subject Terms: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2051-1426 |
| Relation: |
https://jitc.bmj.com/content/10/1/e003190.full; https://doaj.org/toc/2051-1426 |
| DOI: |
10.1136/jitc-2021-003190 |
| Access URL: |
https://doaj.org/article/54582ca5443540829196267e9ec3d8e8 |
| Accession Number: |
edsdoj.54582ca5443540829196267e9ec3d8e8 |
| Database: |
Directory of Open Access Journals |
